Author:
Tas Faruk,Derin Duygu,Guney Nese,Aydiner Adnan,Topuz Erkan
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Reference12 articles.
1. Colombo N, Van Gorp T, Parma G, et al. (2006) Ovarian cancer. Crit Rev Oncol Hematol 60:159–179
2. Parmar MK, Ledermann JA, Colombo N, et al. (2003) Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet 361:2099–2106
3. Pfisterer J, Plante M, Vergote A, et al. (2004) Gemcitabine/carboplatin (GC) vs carboplatin (C) in platinum sensitive recurrent ovarian cancer (OVCA). Results of a Gynecologic Cancer Intergroup randomized phase III trial of the AGO OVAR, the NCIC CTG and the EORTC GCG. Proc Am Soc Clin Oncol 23:449 (Abstract 5005)
4. Muggia FM, Hainsworth JD, Jeffers S, et al. (1997) Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. J Clin Oncol 15:987–993
5. Gordon AN, Granai CO, Rose PG, et al. (2000) Phase II study of liposomal doxorubicin in platinum-and paclitaxel-refractory epithelial ovarian cancer. J Clin Oncol 18:3093–3100
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献